Interstitial fluid pressure in tumors: therapeutic barrier and biomarker of angiogenesis. 2008

Sarah Jane Lunt, and Anthony Fyles, and Richard P Hill, and Michael Milosevic
Division of Applied Molecular Oncology, Princess Margaret Hospital/Ontario Cancer Institute, University Health Network, Department of Medical Biophysics, University of Toronto, Toronto, Canada. s.lunt@sheffield.ac.uk

Interstitial fluid pressure is elevated in virtually all solid malignant tumors as a result of abnormalities of the vasculature and interstitium. High interstitial fluid pressure is an independent predictor of disease recurrence in cervical cancer patients treated with radiotherapy, has been implicated as an important factor that impairs the delivery of chemotherapy to tumors and may influence the regulation and distribution of cytokines and growth factors. Targeted molecular treatments that inhibit angiogenesis or alter interstitial fluid dynamics also produce early reductions in interstitial fluid pressure. Reductions in interstitial fluid pressure due to anti-angiogenic treatment have been associated with improved therapeutic outcome in preclinical studies when these agents are combined with radiotherapy or conventional cytotoxic chemotherapy. Pretreatment interstitial fluid pressure and the change in pressure during treatment may provide important predictive information that in the future will be used to optimize therapy in individual patients.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009389 Neovascularization, Pathologic A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions. Angiogenesis, Pathologic,Angiogenesis, Pathological,Neovascularization, Pathological,Pathologic Angiogenesis,Pathologic Neovascularization,Pathological Angiogenesis,Pathological Neovascularization
D011312 Pressure A type of stress exerted uniformly in all directions. Its measure is the force exerted per unit area. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Pressures
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D045604 Extracellular Fluid The fluid of the body that is outside of CELLS. It is the external environment for the cells. Interstitial Fluid,Intercellular Fluid,Extracellular Fluids,Fluid, Extracellular,Fluid, Intercellular,Fluid, Interstitial,Fluids, Extracellular,Fluids, Intercellular,Fluids, Interstitial,Intercellular Fluids,Interstitial Fluids

Related Publications

Sarah Jane Lunt, and Anthony Fyles, and Richard P Hill, and Michael Milosevic
September 2022, Biochimica et biophysica acta. Reviews on cancer,
Sarah Jane Lunt, and Anthony Fyles, and Richard P Hill, and Michael Milosevic
July 2006, Neuro-oncology,
Sarah Jane Lunt, and Anthony Fyles, and Richard P Hill, and Michael Milosevic
May 2006, Neoplasia (New York, N.Y.),
Sarah Jane Lunt, and Anthony Fyles, and Richard P Hill, and Michael Milosevic
January 1992, Cancer research,
Sarah Jane Lunt, and Anthony Fyles, and Richard P Hill, and Michael Milosevic
December 2012, Journal of orthopaedic research : official publication of the Orthopaedic Research Society,
Sarah Jane Lunt, and Anthony Fyles, and Richard P Hill, and Michael Milosevic
December 1999, Medical hypotheses,
Sarah Jane Lunt, and Anthony Fyles, and Richard P Hill, and Michael Milosevic
September 1997, Microvascular research,
Sarah Jane Lunt, and Anthony Fyles, and Richard P Hill, and Michael Milosevic
September 2015, Journal of theoretical biology,
Sarah Jane Lunt, and Anthony Fyles, and Richard P Hill, and Michael Milosevic
April 2001, Clinical orthopaedics and related research,
Sarah Jane Lunt, and Anthony Fyles, and Richard P Hill, and Michael Milosevic
July 1971, Physiological reviews,
Copied contents to your clipboard!